Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy

NCT02827851 is registered in ClinicalTrials.gov with Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation as lead sponsor.

NCT NCT02827851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02827851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy
Lead sponsor
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2016
Completion date
November 30, 2018
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis